Fortunately, randomized controlled trials were also performed with HFNC in mild to
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …

Purpose High-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line
respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min …

The American Academy of Pediatrics (AAP) guidelines recommend only supportive therapy
for hospitalised infants with viral bronchiolitis. This includes oxygen therapy for hypoxaemia …

Aim To obtain data on the safety and clinical impact of managing infants with bronchiolitis on
the ward with high‐flow nasal cannula (HFNC) treatment. Methods A prospective pilot study …

Background Bronchiolitis imposes the largest health care burden on non-elective paediatric
hospital admissions worldwide, with up to 15% of cases requiring admission to intensive …

Introduction High‐flow nasal cannula (HFNC) is commonly used as first step respiratory
support in infants with moderate‐to‐severe acute viral bronchiolitis (AVB). This device …

Oxygen delivery via a high flow nasal cannula (HFNC) system has become increasingly
common for children with acute viral bronchiolitis. 1 HFNC is now used in pediatric intensive …

Purpose Nasal continuous positive airway pressure (nCPAP) is currently the gold standard
for respiratory support for moderate to severe acute viral bronchiolitis (AVB). Although …

The proliferationof observational literature on the topic of high-flow nasal cannula (HFNC) as
a therapy for acute viral bronchiolitis is nothing short of remarkable. A brief PubMed search …

Aim Using a high‐flow nasal cannula (HFNC) for infant bronchiolitis is increasingly common,
but insufficiently studied. In this retrospective study, we examined the outcomes of HFNC …